NexgenRx Inc.
NXG.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 712.50K | 480.30K | 454.90K | 189.70K | -17.20K |
| Total Depreciation and Amortization | 212.90K | 215.00K | 232.70K | 171.80K | 184.80K |
| Total Amortization of Deferred Charges | 691.90K | 691.90K | 691.90K | 761.50K | 761.50K |
| Total Other Non-Cash Items | 286.30K | 313.70K | 315.60K | 71.60K | 76.00K |
| Change in Net Operating Assets | -637.20K | -441.50K | -1.07M | -451.30K | 169.60K |
| Cash from Operations | 1.27M | 1.26M | 623.40K | 743.50K | 1.17M |
| Capital Expenditure | -236.60K | -72.40K | -62.40K | -50.50K | -84.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -353.40K | -359.60K | -347.90K | -168.50K | -124.80K |
| Cash from Investing | -589.90K | -432.00K | -410.30K | -219.00K | -209.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -125.50K | -115.60K | -102.30K | -98.60K | -89.40K |
| Issuance of Common Stock | 62.50K | 62.50K | 187.50K | 187.50K | 187.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -400.90K | -403.30K | -404.80K | -639.70K | -640.10K |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -33.00K | -- |
| Cash from Financing | -445.50K | -441.00K | -341.40K | -597.80K | -566.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 231.20K | 386.60K | -128.30K | -73.50K | 398.50K |